Systems biology analysis of RNA-binding protein aggregation during cellular aging
Systems biology analysis of RNA-binding protein aggregation during cellular aging
批准号:
10661772
负责人:
Nan Hao
金额:
$45.32万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-15 至 2026-05-31
关键词:
AffectAgeAgingAlzheimer&aposs DiseaseBinding ProteinsBiochemicalBiological ModelsBiophysicsCell AgingCell physiologyCellsCommunitiesComplementComplexControlled EnvironmentDataDeacetylaseDedicationsDiseaseFoundationsGene ExpressionGene Expression RegulationGenesGenomicsImaging technologyIndividualLibrariesLightLinkLiquid substanceLongevityLysineMalignant NeoplasmsMeasurementMediatingMessenger RNAMethodsMicrofluidic MicrochipsMicrofluidicsMicroscopyNeurodegenerative DisordersPathologicPathway interactionsPhasePhase TransitionPhenotypePlayPost-Transcriptional RegulationPrevention strategyProcessPropertyProteinsProteomeProteomicsRNA analysisRNA metabolismRNA-Binding ProteinsRibonucleoproteinsRoleSaccharomyces cerevisiaeSolidStructureSystemSystems BiologyTechnologyTestingYeastsage relatedcellular imagingdata integrationdata sharingdesignexperimental studyfunctional declineinnovationinsightmicrofluidic technologymutantoverexpressionpopulation basedprion-likeprotein aggregationproteostasisresponsescreeningsensortherapeutic developmenttooltranscriptomeweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
RNA-binding proteins (RBPs) play key roles in regulating gene expression and many cellular functions. A lot of
RBPs are aggregation-prone due to their low complexity, prion-like domains. While naturally-occurring
aggregation of RBPs is important for the compartmentalized control of RNA metabolism, aberrant aggregation
is detrimental and is associated with many diseases, in particular, age-related diseases such as
neurodegenerative diseases and cancers. However, a systematic analysis of RBP aggregation and its functional
consequences during aging remains lacking. Here we propose to conduct a systems biology analysis of age-
dependent RBP aggregation using the replicative aging of S.cerevisiae as a model system. Our initial screen
has identified positive RBP candidates that aggregate upon aging-related perturbations. Building upon these
findings, we will combine innovative microfluidics with single-cell imaging technologies to systematically
characterize these RBP aggregates during aging and to evaluate how these aggregates influence gene
expression, aging phenotypes and the lifespan of individual living cells. In Aim 1, we will systematically
characterize each of the identified RBPs that aggregate during aging. We will determine the biophysical and
biochemical properties, material state and phase transition of RBP aggregates at different stages of the lifespan,
which will provide important clues about how these aggregates influence cell physiology during aging. In Aim 2,
we will investigate the interplay between RBP aggregation and cellular aging, focusing on how aggregation of
RBPs is regulated by conserved aging-related pathways or factors, and how these aggregates contribute to age-
dependent cellular changes and the final lifespan. In Aim 3, we will evaluate how RBP aggregation contributes
to the proteomic changes during aging. We will use a newly-developed high-throughput microfluidic platform to
identify target genes that are regulated by RBP aggregation and will examine their influences on aging,
establishing the functional links among RBP aggregation, proteomic changes and aging phenotypes. Finally, we
will integrate all the data generated in Aims 1, 2 and 3, delineate a systems-level regulatory network of RBP
aggregation during yeast replicative aging, and develop a dedicated website for sharing the data to the scientific
community. The RBP-regulated network will provide mechanistic insights into the causes, control and
consequences of pathological RBP aggregation in aging and will be used to guide the design of new hypotheses
and experiments, laying the foundation for the development of therapeutic and preventive strategies towards
age-associated diseases.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Systems biology analysis of RNA-binding protein aggregation during cellular aging
-
批准号:10211598
-
项目类别:
-
资助金额:$45.32万
-
财政年份:2021
-
负责人:Nan Hao
-
依托单位:
Systems biology analysis of RNA-binding protein aggregation during cellular aging
-
批准号:10483171
-
项目类别:
-
资助金额:$45.32万
-
财政年份:2021
-
负责人:Nan Hao
-
依托单位:
A quantitative analysis of dynamic signal processing by transcription factors
-
批准号:9069006
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
Dynamically compartmentalized control of gene expression by messenger ribonucleoprotein granules
-
批准号:10433617
-
项目类别:
-
资助金额:$7.36万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
Dynamically compartmentalized control of gene expression by messenger ribonucleoprotein granules
-
批准号:10437619
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
A quantitative analysis of dynamic signal processing by transcription factors
-
批准号:9272921
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
A quantitative analysis of dynamic signal processing by transcription factors
-
批准号:9484313
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
A quantitative analysis of dynamic signal processing by transcription factors
-
批准号:8750766
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
Dynamically compartmentalized control of gene expression by messenger ribonucleoprotein granules
-
批准号:10389768
-
项目类别:
-
资助金额:$5.7万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
Dynamically compartmentalized control of gene expression by messenger ribonucleoprotein granules
-
批准号:10188554
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
A quantitative analysis of dynamic signal processing by transcription factors
-
批准号:8909136
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2014
-
负责人:Nan Hao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: